The impact of antimicrobial stewardship on reserve antibiotic use and procuring cost
DOI:
https://doi.org/10.46542/pe.2023.234.149153Keywords:
Antimicrobial stewardship, Procuring antibiotic cost, Reserve antibiotic useAbstract
Background: Antimicrobial Stewardship (AMS) is an intervention designed to optimise the appropriate use of antibiotics is expected to reduce selective pressure on microbes, control antimicrobial resistance, improve patient clinical outcomes, and cost reduction.
Objective: The aim of this study is to analyse the impact of antimicrobial stewardship on "reserve" antibiotics use and procuring cost of antibiotics in hospitals.
Method: The study was conducted at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. A retrospective observational design study to analyse trends of "reserve" antibiotics use and procuring cost before AMS implementation (January 2018-December 2019) and after AMS implementation (January 2020-December 2021).
Results: The total meropenem consumption before AMS intervention in January 2018-December 2019 was 9950 DDD, and after AMS intervention in January 2020-December 2021 was 4639 DDD, showing a decrease of 53 %. Procuring Meropenem cost in 2018-2019 was Indonesian Rupiah (IDR) 1.490 billion and IDR 309 million between 2020 to 2021. Cost reduction positively impacts saving procurement costs in hospitals of IDR 1.18 billion (79%).
Conclusion: The impact antimicrobial stewardship programs can reduce reserve antibiotic use with meropenem indicator and have a sustainable economic impact, saving the cost of procuring antibiotics in hospitals.
References
Abushaheen, M. A., Muzaheed, Fatani, A.J., Alosaimi, M., Mansy, W., George, M., Acharya, S., Rathod, S., Divakar, D. D., Jhugroo, C., Vellappally, S., Khan, A. A., Shaik, J., Jhugroo, P. (2020). Antimicrobial resistance, mechanisms and its clinical significance. Disease a Month, 66(6), 100971. https://doi.org/10.1016/j.disamonth.2020.100971.
Barlam, T. F., Cosgrove, S.E., Abbo, L. M., MacDougall, C., Schuetz, A.N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., Hamilton, C. W., Jenkins, T. C., Lipsett, P. A., Malani, P. N., May, L. S., Moran, G. J., Neuhauser, M. M., Newland, J. G., Ohl, C. A., Samore, M. H., Seo, S. K., Trivedi, K. K. (2016). Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis. 62(10), e51-77. https://doi.org/10.1093/cid/ciw118
Center for Diseases Control and Prevention. (2019). The Core Elements of Hospital Antibiotic Stewardship Programs. Accessed: 20 May 2022. Available on: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html
Shridhar. D. P., Anitha, K. B., Rai, M., Fernandes. (2015). A Reserve drug indent form and its impact on antimicrobial consumption and sensitivity pattern in the medical intensive care unit of a tertiary care hospital. Journal of Clinical and Diagnostic Research, 9(2), FC05- https://doi.org/10.7860/JCDR/2015/10974.5593.
Antimicrobial Resistance Collaborators. (2022). Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis, 399(10325), 629-655. https://doi.org/10.1016/S0140-6736(21)02724-0
Kelly, R., & Davies, S. C. ( 2017). Tackling antimicrobial resistance globally. Medical Journal of Australia, 207(9), 371-373. https://doi.org/10.5694/mja17.00865.
Ministry of Health Republic Indonesia. (2021). Regulation of the Minister of Health of the Republic of Indonesia number 28 of 2021 concerning Guidelines for the Use of Antibiotics. Accessed: 20 May 2022. Available at https://www.iccc.or.id/wpcontent/uploads/2021/03/Minister-of-Health-Regulation-No.-10-of-2021-SSEK-Translations.pdf
Limato, R., Nelwan, E. J., Mudia, M., de Brabander, J., Guterres, H., Enty, E., Mauleti, I. Y., Mayasari, M., Firmansyah, I., Hizrani, M., Hamers, R. L. (2021). A multicentre point prevalence survey of patterns and quality of antibiotic prescribing in Indonesian hospitals. JAC Antimicrobial Resistance, 3(2), dlab047. https://doi.org/10.1093/jacamr/dlab047
Mijović, B., Dubravac Tanasković, M., Račić, M., Bojanić, J., Stanić, S., & Banković Lazarević, D. (2018). Outcomes of intrahospital antimicrobial stewardship programs related to prevention of Clostridium difficile infection outbreaks. Medicinski Glasnik, 15(2), 122-131. https://doi.org/10.17392/958-18.
Nathwani, D., Varghese, D., Stephens, J., Ansari, W., Martin S., & Charbonneau, C. (2119). Value of hospital antimicrobial stewardship programs [ASPs]: A systematic review. Antimicrobial Resistance Infectious Control, 8, 35. https://doi.org/10.1186/s13756-019-0471-0
O’Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report And Recommendations. The review on AMR. Accessed: 20 May 2022. Available on: https://apo.org.au/node/63983,
Parathon, H., Kuntaman, K., Widiastoety, T. H., Muliawan, B. T., Karuniawati, A., Qibtiyah, M., Tawilah, J. F., Aditama, T., Tamlikitkul, V., & Vong, S. (2017). Progress Towards Antimicrobial Resistance Containment And Control In Indonesia. https://doi.org/10.1136/bmj.j3808
Peirano, G., Chen, L., Nobrega, D., Finn, T. J., Kreiswirth, B. N., DeVinney, R., & Pitout, J. D. D., (2022). Genomic Epidemiology of Global Carbapenemase-Producing Escherichia coli, 2015– 2017. Emerging Infectious Diseases, 28, 5. https://www.cdc.gov/eid
Septimus, E. (2014). Antimicrobial stewardship-qualitative and quantitative outcomes: The role of measurement. Current Infectious Disease Reports. 16(11), 433. https://doi.org/10.1007/s11908-014-0433-x.
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., Ouellette, M., Outterson, K., Patel, J., Cavaleri, M., Cox, E.M., Houchens, C.R., Grayson, M. L., Hansen, P., Singh, N., Theuretzbacher, U., & Magrini, N. (2018). WHO Pathogens Priority List Working Group. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis, 18(3), 318-327. https://doi.org/10.1016/S1473- 3099(17)30753-3.
Tamma, P. D., Avdic, E., Keenan, J. F., Zhao, Y., Anand, G., Cooper, J., Dezube, R., Hsu, S., & Cosgrove, S. E. (2017). What Is the most effective antibiotic stewardship intervention: Preprescription authorisation or postprescription review with feedback? Clinical Infectious Diseases, 64(5), 537-543. https://doi.org/10.1093/cid/ciw780.
Tompkins, K., & van Duin, D. (2021). Treatment for carbapenem- resistant Enterobacterales infections: Recent advances and future directions. European Journal of Clinical Microbiology Infectious Diseases. 40(10), 2053-2068. https://doi.org/10.1007/s10096-021-04296-1
World Health Organisation. (2021a). Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report. Accessed, 20 May 2022. Available on: https://www.who.int/initiatives/glass
World Health Organisation. (2021b). WHO Access, Watch, Reserve (AWaRe) Classification of antibiotics for evaluation and monitoring of use. Available on: https://apps.who.int/iris/handle/10665/345555
